These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28059042)

  • 1. Alkaloids as Cyclooxygenase Inhibitors in Anticancer Drug Discovery.
    Hashmi MA; Khan A; Farooq U; Khan S
    Curr Protein Pept Sci; 2018; 19(3):292-301. PubMed ID: 28059042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products and their derivatives as cyclooxygenase-2 inhibitors.
    Chandel P; Rawal RK; Kaur R
    Future Med Chem; 2018 Oct; 10(20):2471-2492. PubMed ID: 30325206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer.
    Yu T; Lao X; Zheng H
    Mini Rev Med Chem; 2016; 16(15):1230-1243. PubMed ID: 27145850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
    Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
    Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018).
    Mahboubi Rabbani SMI; Zarghi A
    Expert Opin Ther Pat; 2019 Jun; 29(6):407-427. PubMed ID: 31132889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coumarins scaffolds as COX inhibitors.
    Revankar HM; Bukhari SN; Kumar GB; Qin HL
    Bioorg Chem; 2017 Apr; 71():146-159. PubMed ID: 28222891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their Structural Diversity and Mechanism of Action.
    Mahboubi-Rabbani M; Abbasi M; Zarghi A
    Anticancer Agents Med Chem; 2023; 23(1):15-36. PubMed ID: 35638275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle Arrest.
    Khan H; Alam W; Alsharif KF; Aschner M; Pervez S; Saso L
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed.
    Liu R; Xu KP; Tan GS
    Eur J Pharmacol; 2015 Dec; 769():127-33. PubMed ID: 26548623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.
    Tugcu G; Sipahi H; Aydin A
    Curr Top Med Chem; 2019; 19(13):1121-1128. PubMed ID: 31210111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship.
    Qing ZX; Huang JL; Yang XY; Liu JH; Cao HL; Xiang F; Cheng P; Zeng JG
    Curr Med Chem; 2018; 25(38):5088-5114. PubMed ID: 28933285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies.
    Vosooghi M; Amini M
    Expert Opin Drug Discov; 2014 Mar; 9(3):255-67. PubMed ID: 24483845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
    Lamie PF; Ali WAM; Bazgier V; Rárová L
    Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hit identification and biological evaluation of anticancer pyrazolopyrimidines endowed with anti-inflammatory activity.
    Alcaro S; Artese A; Botta M; Zizzari AT; Orallo F; Ortuso F; Schenone S; Brullo C; Yáñez M
    ChemMedChem; 2010 Aug; 5(8):1242-6. PubMed ID: 20564576
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of Natural Bioactive Alkaloids: Anticancer Perspective.
    Patel A; Vanecha R; Patel J; Patel D; Shah U; Bambharoliya T
    Mini Rev Med Chem; 2022; 22(2):200-212. PubMed ID: 34254913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring plant isoquinoline N-oxide alkaloids: their pharmacological and SAR activities.
    Dembitsky VM; Gloriozova TA; Poroikov VV
    Phytomedicine; 2015 Jan; 22(1):183-202. PubMed ID: 25636889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-target inhibitors based on COX-2: a review from medicinal chemistry perspectives.
    Zhang F; Zhu G; Li Y; Qi Y; Wang Z; Li W
    Future Med Chem; 2023 Dec; 15(23):2209-2233. PubMed ID: 38095081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Product Inhibitors of Cyclooxygenase (COX) Enzyme: A Review on Current Status and Future Perspectives.
    Ambati GG; Jachak SM
    Curr Med Chem; 2021; 28(10):1877-1905. PubMed ID: 32484764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations.
    Tseng TS; Chuang SM; Hsiao NW; Chen YW; Lee YC; Lin CC; Huang C; Tsai KC
    Mol Biosyst; 2016 Jul; 12(8):2541-51. PubMed ID: 27265567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.